Mistletoe therapy plays a major role in complementary cancer therapy. The white berry mistletoe (Viscum album) is the most commonly used – and most thoroughly tested – medicinal product in complementary oncology. To date, mistletoe’s effects on various malignant diseases have been researched in over 100 clinical trials – and 26 of these trials used Helixor products, the same product used at PCNM.
Mistletoe is most visible in the winter months, when deciduous trees have lost their leaves and you can see spheres of evergreen leaves on the bare branches. Mistletoe (Viscum album) is a semi-parasite that lives on trees. In the plant kingdom, it stands apart: It has no roots, only a so-called “sinker” that connects the mistletoe to the host tree and supplies it with water, salts, and some nutrients. Unlike all other plants, the mistletoe reproduces in winter, blooming in February/March and bearing ripe, white berries in November/December.The mistletoe does not orient itself to the sun, so both sides of its leaves are identical and its branches grow out into all directions – giving it its spherical shape.In Europe, there are three subspecies of white-berry mistletoe: deciduous tree, pine and fir mistletoe.
The mistletoe contains over 1,000 different constituents. The effects of its proteins – lectins (glycoproteins) and viscotoxins (polypeptides) – and complex carbohydrates (polysaccharides) have been researched most extensively.
Mistletoe therapy acts on many levels: On the one hand, it boosts the immune system by multiplying and activating the immune cells. On the other, mistletoe therapy can induce apoptosis (the process of natural cell death) in tumour cells which results in the inhibition of tumour growth. Healthy tissue is not adversely affected by this. On the contrary: Immune cells and other healthy cells are protected against further injury, e.g. damage caused by chemotherapeutics.
Patients report that mistletoe therapy significantly improves their quality of life. For example:
- Improved general well-being
- Less fatigue, especially during and after chemotherapy
- Less nausea
- Improved appetite
- Less pain sensation, so fewer painkillers and sedatives are needed
- Less frequent depressive moods
This mode of action makes mistletoe therapy a key supplement with standard oncological therapy.
You can find more information about mistletoe therapy on the Helixor website.